BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,717,998 | +11.5% | 631,581 | +40.3% | 0.01% | 0.0% |
| Q2 2023 | $28,451,944 | +34.0% | 450,189 | -4.6% | 0.01% | +20.0% |
| Q1 2023 | $21,236,720 | +106.5% | 472,032 | +101.1% | 0.01% | +150.0% |
| Q4 2022 | $10,285,580 | -35.1% | 234,777 | -2.4% | 0.00% | -50.0% |
| Q3 2022 | $15,858,000 | +82.2% | 240,668 | +39.7% | 0.00% | +300.0% |
| Q2 2022 | $8,703,000 | -16.5% | 172,289 | +5.6% | 0.00% | -50.0% |
| Q1 2022 | $10,426,000 | -48.6% | 163,208 | -13.8% | 0.00% | – |
| Q4 2021 | $20,288,000 | +38.7% | 189,408 | +33.2% | 0.00% | -100.0% |
| Q3 2021 | $14,622,000 | +5.8% | 142,220 | -9.5% | 0.00% | 0.0% |
| Q2 2021 | $13,825,000 | +79.1% | 157,175 | +97.9% | 0.00% | -50.0% |
| Q1 2021 | $7,721,000 | -83.7% | 79,409 | -81.2% | 0.00% | -33.3% |
| Q4 2020 | $47,488,000 | +124.1% | 423,426 | +85.3% | 0.00% | -25.0% |
| Q3 2020 | $21,189,000 | -4.5% | 228,568 | -19.7% | 0.00% | -20.0% |
| Q2 2020 | $22,198,000 | -31.4% | 284,593 | -48.6% | 0.01% | -50.0% |
| Q1 2020 | $32,348,000 | +51.0% | 553,160 | +106.9% | 0.01% | +66.7% |
| Q4 2019 | $21,419,000 | -55.3% | 267,382 | -59.0% | 0.01% | -62.5% |
| Q3 2019 | $47,962,000 | -61.7% | 652,815 | -50.8% | 0.02% | 0.0% |
| Q2 2019 | $125,080,000 | +944.3% | 1,325,966 | +786.2% | 0.02% | +300.0% |
| Q1 2019 | $11,977,000 | +124.0% | 149,618 | +50.8% | 0.00% | +100.0% |
| Q4 2018 | $5,348,000 | -52.8% | 99,200 | -31.6% | 0.00% | -50.0% |
| Q3 2018 | $11,319,000 | -55.1% | 145,000 | -63.5% | 0.00% | -55.6% |
| Q2 2018 | $25,190,000 | +107.5% | 396,815 | +199.7% | 0.01% | +125.0% |
| Q1 2018 | $12,141,000 | -21.0% | 132,400 | -35.0% | 0.00% | -20.0% |
| Q4 2017 | $15,366,000 | +420.2% | 203,766 | +380.6% | 0.01% | +150.0% |
| Q3 2017 | $2,954,000 | +118.5% | 42,400 | +58.8% | 0.00% | – |
| Q2 2017 | $1,352,000 | -31.0% | 26,700 | -45.5% | 0.00% | -100.0% |
| Q1 2017 | $1,960,000 | +180.8% | 49,000 | +96.8% | 0.00% | – |
| Q4 2016 | $698,000 | +33.5% | 24,900 | +41.5% | 0.00% | – |
| Q3 2016 | $523,000 | +85.5% | 17,600 | +64.5% | 0.00% | – |
| Q4 2015 | $282,000 | – | 10,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |